Q-linea AB (publ) announced that Stuart Gander succeeds Jonas Jarvius as CEO. Stuart Gander brings extensive experience from leading positions in the global healthcare industry, with a focus on diagnostics and medical technologies. Through his management consulting background, he has supported companies on a range of operational challenges with a focus on driving sustainable change and growth, based on building strong and motivated teams. Stuart Gander is a Canadian citizen, has previously been working 15 years in Sweden, is currently living in the USA but will relocate to Sweden within the next 18 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.295 SEK | +64.91% | +59.56% | -10.95% |
Mar. 13 | Q-linea AB Presents Strong ASTar Results At AMCLI | CI |
Feb. 27 | Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.95% | 35.11M | |
-12.91% | 19.08B | |
-46.21% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+23.78% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-7.14% | 716M | |
-18.10% | 682M |
- Stock Market
- Equities
- QLINEA Stock
- News Q-linea AB
- Q-linea AB Announces CEO Changes